Quick orientationEvidence update: 6 October 2026
What is MOTS-c?
MOTS-c is unusual because it is a mitochondrial-derived peptide - essentially a message linked to the little energy-producing structures inside our cells.
Why people are interested
The potential benefits, unpacked.
Here are the goals and claims that bring readers to this guide. The evidence note shows which part is demonstrated, early research or still a question.
The headline interest
Strongest evidence is cell/animal; human observational and exercise-related work is early.
What the mechanism suggests
Mitochondrial-derived peptide linked to AMPK/metabolic stress signalling and exercise adaptation in preclinical research.
What still needs proving
The key question is whether the claimed benefit has been demonstrated in controlled human studies using the same compound, route and population.
What is it actually doing?
Mitochondrial-derived peptide linked to AMPK/metabolic stress signalling and exercise adaptation in preclinical research.
The important distinction is between changing a biomarker or pathway and producing a meaningful outcome that people can feel, measure or sustain.
Results at a glanceHuman evidence
What did the studies actually find?
Human study deep dive
The most informative human evidence we could identify is translated below, with the original source linked.
Study evidenceStudy deep dives
The important studies, translated into normal English.
Each synopsis keeps the trial design, actual results and limitations together. Graphs below are redrawn from the cited numerical results so you can see the size of the effect without having to decode a journal figure.
Exercise-induced MOTS-c study — Nature Communications 2021
Human exercise observations plus cell and mouse experimentsThe paper found MOTS-c responds to exercise biology in humans and demonstrated improved physical performance and metabolic adaptation in mice. It did not test MOTS-c injections as an exercise drug in a human RCT.
Interesting human biology plus strong preclinical work is not the same as demonstrated human treatment efficacy.
What it doesn't prove: Most intervention evidence was in mice; no established human therapeutic dose follows from this paper.
Read the original study / source ↗
Dosing referenceResearch, licensed & reported protocols
What doses and schedules are actually documented?
Human research or licensed product information is separated from clinic and community practice. These are source-attributed reference protocols, not personalised dosing recommendations.
Human research / licensed or product dosing
| Protocol / context | Amount & frequency | Duration | Titration | Evidence |
|---|---|---|---|---|
| Human evidence | Published human work mainly measures endogenous MOTS-c responses; no completed human dose-finding/efficacy trial establishing an administered dose | — | — | No validated human administration regimen |
Community / clinic / specialist protocols
| Pattern | Amount & frequency | Cycle | Progression | Status |
|---|---|---|---|---|
| 20-day pulsed convention | 5 mg SC every 5 days | 20 days / 4 doses; often repeated a few times/year | Fixed | Clinic/community |
| Intensive convention | 5 mg SC 3× weekly | 4–6 weeks | Fixed | Community |
| Higher intermittent | 10 mg SC 1–3× weekly | 4–10 weeks depending source | Usually fixed | Community |
| 8-week phased | 5 mg 3× weekly weeks 1–4 →5 mg weekly weeks 5–8 | 8 weeks; ~4-week break | Frequency taper | Community database |
| Daily microdose ladder | 200→400→600→800→1000 mcg daily | 2 weeks at each step | 200 mcg increments every 2 Specia weeks eviden | list/community; weak ce |
The administered human dose is unknown. Online 5–10 mg schedules are community/clinic conventions, not clinical-trial doses. PP should say this prominently.
Evidence checked: 7 October 2026
Routes and formulations matter. A topical study does not validate injection; an IV research dose does not establish a fixed SC dose; and evidence for one molecular form must not be silently transferred to another.
Community reportsCommunity reports
What are people actually doing?
Community experience exists, but is anecdotal
Forums discuss schedules, effects and side effects, but posts are uncontrolled self-reports and product identity may be uncertain. Use them to understand what people report—not to estimate efficacy or establish a dose.
View the discussion on Reddit ↗
Safety and uncertaintySafety, side effects & what we don't know
Not an established treatment for energy, ageing or metabolic disease.
Product identity, sterility and concentration are additional uncertainties for unlicensed research products. Evidence from an approved medicine or a clinical trial should not be transferred automatically to a differently sourced product.
QuestionsQuestions worth asking
What is the strongest evidence here?
Interesting human biology plus strong preclinical work is not the same as demonstrated human treatment efficacy.
Does a biological mechanism prove the claimed benefit?
No. Receptor activity, cell effects and animal results can justify research, but controlled human outcomes are a separate evidential step.
Is the research protocol a recommended dose?
No. The site reports study protocols to explain the evidence. It does not turn them into personalised self-use instructions.
Primary sourcesStudies, sources & further reading
External links are provided for transparency and further reading. Linking to a study, discussion or organisation does not mean Peptides Peptalk endorses every conclusion on that page.